The store will not work correctly when cookies are disabled.
The page will load shortly, Thanks for your patience!
| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source |
| 1. | ALA5052860 | B | Binding affinity towards GIP receptor in human HEK293 cells measured by fluorescence assay | Homo sapiens | 10 | | cell-based format | Patent Bioactivity Data |
| 2. | ALA5052861 | B | Binding affinity towards GLP-2 receptor in human HEK293 cells measured by fluorescence assay | Homo sapiens | 9 | | cell-based format | Patent Bioactivity Data |
| 3. | ALA5052862 | F | Inhibition of RANKL-induced osteoclastogenesis in mouse RAW264.7 cells measured after 110 hrs by TRAcP staining based assay | Mus musculus | 10 | | cell-based format | Patent Bioactivity Data |
| 4. | ALA5052869 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 100 nmol/kg/day, sc assessed as increase in ultimate displacement of cortical bone | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 5. | ALA5052870 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 100 nmol/kg/day, sc assessed as increase in post-yield displacement of cortical bone | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 6. | ALA5052871 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 100 nmol/kg/day, sc assessed as increase in work-to-fracture of cortical bone | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 7. | ALA5052873 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 to 100 nmol/kg/day, sc assessed as effect on cortical bone microarchitecture | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 8. | ALA5052876 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 to 100 nmol/kg/day, sc assessed as reduction in trabecular bone stiffness | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 9. | ALA5052880 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as reduction in trabecular spacing | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 10. | ALA5052885 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 100 nmol/kg, sc assessed as decrease in mean phosphate/amide ratio | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 11. | ALA5052886 | F | Anti-osteoporosis activity in ovariectomized BALB/c mouse at 100 nmol/kg, sc assessed as decrease in augmented acid phosphate content heterogeneity | Mus musculus | 1 | | organism-based format | Patent Bioactivity Data |
| 12. | ALA5052888 | T | Toxicity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as effect on morphological changes in liver | Mus musculus | 2 | | organism-based format | Patent Bioactivity Data |
| 13. | ALA5052889 | T | Toxicity in ovariectomized BALB/c mouse at 25 nmol/kg, sc assessed as effect on morphological changes in pancreas | Mus musculus | 2 | | organism-based format | Patent Bioactivity Data |